Open Access iconOpen Access

ARTICLE

crossmark

Reversal of tamoxifen resistance by artemisinin in ER+ breast cancer: bioinformatics analysis and experimental validation

ZHILI ZHUO#, DONGNI ZHANG#, WENPING LU*, XIAOQING WU, YONGJIA CUI, WEIXUAN ZHANG, MENGFAN ZHANG

Department of Oncology, China Academy of Chinese Medical Sciences Guang’anmen Hospital, Beijing, China

* Corresponding Author: WENPING LU. Email: email

TSP_OR_47257.pdf

  • 915

    View

  • 231

    Download

  • 0

    Like

Share Link